# Ciclesonide vs Fluticasone Nasal Sprays in Nasal Poplyposis

> **NCT02665806** · PHASE3 · UNKNOWN · sponsor: **Tehran University of Medical Sciences** · enrollment: 32 (estimated)

## Conditions studied

- Chronic Rhinosinustis With Polyps

## Interventions

- **DRUG:** Ciclesonide
- **DRUG:** Fluticasone

## Key facts

- **NCT ID:** NCT02665806
- **Lead sponsor:** Tehran University of Medical Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-01
- **Primary completion:** 2016-02
- **Final completion:** 2016-03
- **Target enrollment:** 32 (ESTIMATED)
- **Last updated:** 2016-01-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02665806

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02665806, "Ciclesonide vs Fluticasone Nasal Sprays in Nasal Poplyposis". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT02665806. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*